Browse Drug Recalls
14,380 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,380 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 18, 2017 | FOLINIC ACID MDV (CALIF) 5MG/ML INJ, Injection, 5mg/mL, Rx only, packaged in ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 45.45/27.27/0.45 5ML MDV MCG/MG/MG/ML INJ, Injection, 45.45mcg/27.27m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FOLINIC ACID MDV INJ, Injection, 10 mg/mL, Rx only, packaged in 2mL and 10 mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 PBF MDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, packaged in a 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1/CPZ 5ML MDV 20MCG/1MG/ML INJ, Injection, 20mcg/1mg/mL, Rx only, 5 mL Gla... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | METHYL-B12 5ML MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 5 mL Glass... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 10/30/0.5 *5ML* MDV MCG/MG/MG/ML INJ, Injection,10mcg/30mg/0.5mg/mL, ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ, Injection, 25mg/mL, Rx only, 20mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 6/18/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 6mcg/18mg/0.6mg/mL, Rx ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1 5ML MDV INJ, Injection, 40mcg/mL, Rx only, 5mL glass/Multiple Dose vial... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | VIT C/GSH 1.25%-1.25% OPHTH, Ophthalmic, 1.25%, Rx only, 15 mL Plastic/ Multi... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 17, 2017 | ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC:... | cGMP Deviations; lack of quality assurance. | Class II | American Pharmaceutical Ingredients LLC |
| Apr 17, 2017 | EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, table... | CGMP deviations: Lots were recalled due to sub-potency and cGMP violations. | Class II | Syntho Pharmaceuticals, Inc. |
| Apr 17, 2017 | EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,10... | CGMP deviations: Lots were recalled due to sub-potency and cGMP violations. | Class II | Syntho Pharmaceuticals, Inc. |
| Apr 13, 2017 | Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Pl... | CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall n... | Class II | Spectrum Laboratory Products, Inc. |
| Apr 13, 2017 | Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg con... | CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall n... | Class II | Spectrum Laboratory Products, Inc. |
| Apr 6, 2017 | Estrone, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-... | cGMP Deviations: lack of quality assurance at the API manufacturer. | Class II | Fagron, Inc |
| Apr 6, 2017 | Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Onl... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Testosterone Cypionate 200 mg/mL, Testosterone Propionate 20 mg/mL, 30 mL Mul... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Triamcinolone Acetonide 40 mg/mL, Lidocaine HCl 10 mg/mL , 10 mL Multi-Dose V... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Fentanyl Citrate (Preservative Free) 10 mcg per mL (1,000 mcg per 100 mL) 100... | Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expira... | Class II | PharMedium Services, Llc |
| Apr 6, 2017 | Estriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-... | cGMP Deviations: lack of quality assurance at the API manufacturer. | Class II | Fagron, Inc |
| Apr 6, 2017 | Methylprednisolone Acetate 40 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Phenylephrine 2.5%, Tropicamide 1%, 15 mL Multi-Dose Ophthalmic (spelled Opth... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Fentanyl Citrate (Preservative Free) 20 mcg per mL (2,000 mcg per 100 mL) 100... | Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expira... | Class II | PharMedium Services, Llc |
| Apr 6, 2017 | Methylprednisolone Acetate 80 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 3, 2017 | ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-08... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | Refresh Tears (Carboxymethylcellulose Sodium Solution) 0.5%, Lubricant Eye Dr... | Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information a... | Class II | Cell Distributors |
| Apr 3, 2017 | ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 gram... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Apr 3, 2017 | ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100... | cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a r... | Class II | Medisca, Inc. |
| Mar 30, 2017 | Alka-Seltzer Original ( 325 mg Aspirin (NSAID), 1916 mg Analgesic, Sodium bic... | Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister... | Class II | Bayer HealthCare Pharmaceuticals, Inc. |
| Mar 30, 2017 | Alka-Seltzer Gold (1000 mg Anhydrous citric acid, 344 mg Antacid Potassium b... | Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister... | Class II | Bayer HealthCare Pharmaceuticals, Inc. |
| Mar 30, 2017 | Alka-Seltzer Extra Strength (500 mg Aspirin (NSAID), 1985 mg Analgesic Sodium... | Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister... | Class II | Bayer HealthCare Pharmaceuticals, Inc. |
| Mar 28, 2017 | Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units a... | Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability | Class II | Taro Pharmaceuticals U.S.A., Inc. |
| Mar 28, 2017 | hCG Body Shaper, Highly Purified Human Chorionic Gonadotrophin 5000 IU, Collo... | Marketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with huma... | Class II | Gary Wood |
| Mar 24, 2017 | Estriol Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estradiol Micronized Bulk, Rx only, For Prescription Compounding, Manufacture... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufac... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Estradiol Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, M... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Ethinyl Estradiol Micronized, USP, Bulk, Rx only, For Prescription Compoundin... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 24, 2017 | Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compoundi... | cGMP Deviations; lack of quality assurance. | Class II | Qinhuangdao Zizhu Pharmaceutical, Co. |
| Mar 22, 2017 | Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 20... | Defective Delivery System: Elevated number of units with out of specification results for leak rate. | Class II | GlaxoSmithKline, LLC |
| Mar 21, 2017 | Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) p... | Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identifi... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.